350 related articles for article (PubMed ID: 31349643)
1. Surface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications.
Zhang B; Liang R; Zheng M; Cai L; Fan X
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349643
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods.
Zhang B; Chen Z; Han J; Li M; Nayak NR; Fan X
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247484
[TBL] [Abstract][Full Text] [Related]
3. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice.
Zhang B; Tan L; Yu Y; Wang B; Chen Z; Han J; Li M; Chen J; Xiao T; Ambati BK; Cai L; Yang Q; Nayak NR; Zhang J; Fan X
Theranostics; 2018; 8(10):2765-2781. PubMed ID: 29774074
[No Abstract] [Full Text] [Related]
4. Trophoblast-Targeted Liposomes for Placenta-Specific Drug Delivery.
Zhang B; Fan X; Nayak NR
Methods Mol Biol; 2024; 2728():173-180. PubMed ID: 38019401
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy.
Figueroa-Espada CG; Hofbauer S; Mitchell MJ; Riley RS
Adv Drug Deliv Rev; 2020; 160():244-261. PubMed ID: 32956719
[TBL] [Abstract][Full Text] [Related]
6. Dynamic placenta-on-a-chip model for fetal risk assessment of nanoparticles intended to treat pregnancy-associated diseases.
Shojaei S; Ali MS; Suresh M; Upreti T; Mogourian V; Helewa M; Labouta HI
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166131. PubMed ID: 33766738
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines: An approach to treat placental insufficiency and the current challenges.
van Kammen CM; van Woudenberg SJ; Schiffelers R; Terstappen F; Lely AT
J Control Release; 2023 Aug; 360():57-68. PubMed ID: 37330012
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles.
Zhang B; Zheng M; Cai L; Fan X
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295666
[TBL] [Abstract][Full Text] [Related]
9. Novel Technologies for Target Delivery of Therapeutics to the Placenta during Pregnancy: A Review.
Pepe GJ; Albrecht ED
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440429
[TBL] [Abstract][Full Text] [Related]
10. The Placental Barrier: the Gate and the Fate in Drug Distribution.
Tetro N; Moushaev S; Rubinchik-Stern M; Eyal S
Pharm Res; 2018 Feb; 35(4):71. PubMed ID: 29476301
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure.
Menezes V; Malek A; Keelan JA
Curr Pharm Biotechnol; 2011 May; 12(5):731-42. PubMed ID: 21342124
[TBL] [Abstract][Full Text] [Related]
12. Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications?
Harris LK
Nanomedicine (Lond); 2016 Sep; 11(17):2235-8. PubMed ID: 27487963
[No Abstract] [Full Text] [Related]
13. Placenta-targeted treatment strategies: An opportunity to impact fetal development and improve offspring health later in life.
Ganguly E; Hula N; Spaans F; Cooke CM; Davidge ST
Pharmacol Res; 2020 Jul; 157():104836. PubMed ID: 32344051
[TBL] [Abstract][Full Text] [Related]
14. Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.
King A; Ndifon C; Lui S; Widdows K; Kotamraju VR; Agemy L; Teesalu T; Glazier JD; Cellesi F; Tirelli N; Aplin JD; Ruoslahti E; Harris LK
Sci Adv; 2016 May; 2(5):e1600349. PubMed ID: 27386551
[TBL] [Abstract][Full Text] [Related]
15. Role of Exosomes in Placental Homeostasis and Pregnancy Disorders.
Salomon C; Rice GE
Prog Mol Biol Transl Sci; 2017; 145():163-179. PubMed ID: 28110750
[TBL] [Abstract][Full Text] [Related]
16. Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Ilekis JV; Tsilou E; Fisher S; Abrahams VM; Soares MJ; Cross JC; Zamudio S; Illsley NP; Myatt L; Colvis C; Costantine MM; Haas DM; Sadovsky Y; Weiner C; Rytting E; Bidwell G
Am J Obstet Gynecol; 2016 Jul; 215(1 Suppl):S1-S46. PubMed ID: 26972897
[TBL] [Abstract][Full Text] [Related]
17. Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs.
Myllynen P; Pienimäki P; Vähäkangas K
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):489-94. PubMed ID: 16023691
[TBL] [Abstract][Full Text] [Related]
18. Maternal exposure to CeO
Zhong H; Geng Y; Chen J; Gao R; Yu C; Yang Z; Chen X; Mu X; Liu X; He J
J Hazard Mater; 2020 May; 389():121830. PubMed ID: 31836366
[TBL] [Abstract][Full Text] [Related]
19. Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.
Zhao K; Li D; Cheng G; Zhang B; Han J; Chen J; Wang B; Li M; Xiao T; Zhang J; Zhou D; Jin Z; Fan X
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683965
[TBL] [Abstract][Full Text] [Related]
20. Altered maternal and placental lipid metabolism and fetal fat development in obesity: Current knowledge and advances in non-invasive assessment.
Delhaes F; Giza SA; Koreman T; Eastabrook G; McKenzie CA; Bedell S; Regnault TRH; de Vrijer B
Placenta; 2018 Sep; 69():118-124. PubMed ID: 29907450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
